BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.
On August 12, BlackRock increased its stake in Sinopharm Tech (01801) by 139,500 shares, at a price of HKD 95.375 per share, for a total amount of approximately HKD 13,304,800.
According to the latest information from the Hong Kong Stock Exchange, on August 12, BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share, totaling approximately HKD 13.3048 million. After this increase, the latest number of shares held is approximately 87,317,900, representing a holding percentage of 5.01%.
Related Articles
CHINAGOLDINTL (02099): The slope management plan for Changshanhao Mine has been approved, and mining operations are expected to resume.
TENGY ENV (01527) has issued a profit warning, expecting the mid-term net profit to increase approximately 698.36% year-on-year to about 126 million yuan.
From the perspective of garlic-scented village life, we see how PDD Holdings Inc. Sponsored ADR Class A (PDD.US) empowers rural areas through its practice of "free delivery to villages," injecting fresh vitality into the economy.
CHINAGOLDINTL (02099): The slope management plan for Changshanhao Mine has been approved, and mining operations are expected to resume.
TENGY ENV (01527) has issued a profit warning, expecting the mid-term net profit to increase approximately 698.36% year-on-year to about 126 million yuan.
From the perspective of garlic-scented village life, we see how PDD Holdings Inc. Sponsored ADR Class A (PDD.US) empowers rural areas through its practice of "free delivery to villages," injecting fresh vitality into the economy.
RECOMMEND
